Navigation Links
Decision Resources, Inc. Acquires Manhattan Research
Date:6/17/2008

Acquisition Expands Decision Resources, Inc.'s Portfolio to Include Global

Physician and Consumer Digital Market Research

WALTHAM, Mass. and NEW YORK, June 17 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired Manhattan Research, a leading provider of access to physician and consumer opinions on the global healthcare market. The acquisition of New York, NY-based Manhattan Research by Waltham, MA-based Decision Resources, Inc. will result in a significant expansion of Decision Resources, Inc.'s portfolio of premier market research and data businesses for the healthcare industry and give Decision Resources, Inc. a larger footprint in the consumer market research arena.

Manhattan Research's focus on physician and consumer use of information technology, including next generation digital media such as social networking, blogs, podcasts, and Web 2.0, sets the firm apart in the industry.

"We are excited to continue our growth as a Decision Resources, Inc. company," said Mark Bard, president and co-founder of Manhattan Research. "We look forward to continuing to expand our portfolio of client solutions with the economic and strategic resources now afforded to us as a member of the Decision Resources, Inc. family."

With more than half of all consumers using the Internet for health information and services, Manhattan Research services are in demand by marketing savvy life sciences organizations.

"Our innovative approach to strategic research and advisory services offers our clients a unique perspective on how physicians and consumers are gathering healthcare information through digital marketing vehicles," said Joe Farris, COO and co-founder of Manhattan Research. "Combining our insight with the industry expertise of Decision Resources, Inc. will provide our clients with a greater understanding of how to reach their target audience and craft their messages in line with evolving macro trends in the industry."

Acquisition Fulfills the Demand for Global Consumer and Physician Market Research

By sub-segmenting their research populations into therapeutic and specialist groups as well as showing utilization and motivation behind the usage behaviors, Manhattan Research expands Decision Resources, Inc.'s offering to include the type of consumer and physician market research that brand managers at biopharmaceutical companies urgently need.

"Manhattan Research is an important acquisition in Decision Resources, Inc.'s overall strategy to expand our portfolio of companies with firms that offer innovative, high-value market research solutions to the healthcare industry," said Peter Hoenigsberg, CEO of Decision Resources, Inc. "The digital age has brought a wealth of healthcare information to physicians and consumers, and Manhattan Research is at the forefront of measuring and analyzing the impact of that information and turning it into actionable lessons-learned for life sciences organizations. This area of market research will continue to be one of the most dynamic for years to come."

Manhattan Research will remain headquartered in New York, NY.

About Manhattan Research

Manhattan Research is a healthcare market research and advisory services firm, bringing clarity to the market forces, trends, and impacts of physician and consumer use of information technology, including next generation digital media such as social networking, blogs, podcasts, and Web 2.0. Through analysis of Manhattan Research's trended, proprietary data sets analysts provide global pharmaceutical companies with the insight necessary to strategically plan and market existing and future therapies. Manhattan Research was advised by AdMedia Partners, an independent merger and acquisition advisory firm based in New York City that provides M&A advice to digital and traditional media, marketing and information businesses.

About Decision Resources

Decision Resources, Inc. is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The company provides insight on the managed care industry (http://www.HealthLeaders-InterStudy.com), the medical device industry (http://www.MRG.net), the biopharmaceutical industry (http://www.DecisionResources.com), the hospital-based drug and imaging industry (http://www.AMR-data.com) and U.S. formulary data (http://www.FingertipFormulary.com).

All company, brand, or product names contained in this document may be

trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. QLT announces positive Health Canada decision on Aczone(R)
2. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
3. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
4. MammaPrint(R) Breast Cancer Test Provides Valuable Insight for Personalized Treatment Decisions
5. Better business decisions with real-time data
6. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers
7. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
8. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
9. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
10. Scientists Using Social Media to Inform Lab Purchasing Decisions
11. NPS Pharmaceuticals to Report Third Quarter 2007 Financial Results and Nycomed Decision on GATTEX(TM) Partnership on November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell ... RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
Breaking Biology Technology:
(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):